Juliet N. Barker

81.0k total citations · 12 hit papers
559 papers, 31.3k citations indexed

About

Juliet N. Barker is a scholar working on Immunology, Hematology and Dermatology. According to data from OpenAlex, Juliet N. Barker has authored 559 papers receiving a total of 31.3k indexed citations (citations by other indexed papers that have themselves been cited), including 259 papers in Immunology, 165 papers in Hematology and 134 papers in Dermatology. Recurrent topics in Juliet N. Barker's work include Psoriasis: Treatment and Pathogenesis (160 papers), Hematopoietic Stem Cell Transplantation (150 papers) and Dermatology and Skin Diseases (105 papers). Juliet N. Barker is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (160 papers), Hematopoietic Stem Cell Transplantation (150 papers) and Dermatology and Skin Diseases (105 papers). Juliet N. Barker collaborates with scholars based in United States, United Kingdom and Germany. Juliet N. Barker's co-authors include C.E.M. Griffiths, Frank O. Nestlé, Daniel H. Kaplan, John E. Wagner, Catherine Smith, Todd E. DeFor, Daniel J. Weisdorf, D.M. MACDONALD, Francesca Capon and Richard C. Trembath and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Juliet N. Barker

523 papers receiving 30.5k citations

Hit Papers

Psoriasis 1991 2026 2002 2014 2009 2007 2021 2004 2002 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Psoriasis
    2009 2.2k citations Juliet N. Barker et al. profile →
  2. Pathogenesis and clinical features of psoriasis
    2007 1.6k citations C.E.M. Griffiths, Juliet N. Barker profile →
  3. Psoriasis
    2021 1.4k citations C.E.M. Griffiths, Juliet N. Barker et al. profile →
  4. Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia
    2004 783 citations Mary Eapen, John E. Wagner et al. profile →
  5. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival
    2002 743 citations John E. Wagner, Juliet N. Barker et al. Blood profile →
  6. Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors
    2001 643 citations Juliet N. Barker, John E. Wagner et al. profile →
  7. Keratinocytes as initiators of inflammation
    1991 637 citations Juliet N. Barker, C.E.M. Griffiths et al. profile →
  8. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation
    2014 614 citations Ying Taur, Robert R. Jenq et al. Blood profile →
  9. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy
    2004 597 citations Juliet N. Barker, Daniel J. Weisdorf et al. Blood profile →
  10. Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions
    2010 538 citations Juliet N. Barker et al. Journal of Investigative Dermatology profile →
  11. Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey
    2014 411 citations Juliet N. Barker, P.C.M. van de Kerkhof et al. profile →
  12. Psoriasis: a brief overview
    2021 216 citations Satveer K. Mahil, Juliet N. Barker et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juliet N. Barker United States 85 17.3k 9.0k 8.4k 5.1k 4.4k 559 31.3k
Peter Valent Austria 97 16.7k 1.0× 3.4k 0.4× 9.6k 1.1× 4.3k 0.8× 9.7k 2.2× 900 40.5k
Alice B. Gottlieb United States 90 23.1k 1.3× 12.3k 1.4× 5.4k 0.6× 2.1k 0.4× 2.5k 0.6× 602 31.4k
John J. O’Shea United States 110 31.2k 1.8× 2.4k 0.3× 3.5k 0.4× 15.2k 3.0× 11.2k 2.5× 323 49.8k
Mark Lebwohl United States 94 23.0k 1.3× 18.1k 2.0× 2.8k 0.3× 2.6k 0.5× 3.4k 0.8× 847 36.1k
J. Daniel United States 70 26.8k 1.5× 3.6k 0.4× 2.4k 0.3× 5.6k 1.1× 8.3k 1.9× 129 38.8k
James G. Krueger United States 126 30.7k 1.8× 25.1k 2.8× 2.3k 0.3× 6.3k 1.2× 6.8k 1.5× 495 49.7k
Alan Menter United States 80 19.1k 1.1× 12.2k 1.4× 2.6k 0.3× 1.8k 0.3× 2.0k 0.4× 387 25.4k
Enrico Maggi Italy 83 15.6k 0.9× 2.6k 0.3× 1.0k 0.1× 3.9k 0.8× 3.6k 0.8× 367 27.2k
Olivier Hermine France 90 11.9k 0.7× 970 0.1× 3.8k 0.5× 6.3k 1.2× 7.1k 1.6× 822 29.8k
Georg Schett Germany 118 18.0k 1.0× 2.2k 0.2× 6.1k 0.7× 8.7k 1.7× 21.6k 4.9× 1.1k 59.6k

Countries citing papers authored by Juliet N. Barker

Since Specialization
Citations

This map shows the geographic impact of Juliet N. Barker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juliet N. Barker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juliet N. Barker more than expected).

Fields of papers citing papers by Juliet N. Barker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juliet N. Barker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juliet N. Barker. The network helps show where Juliet N. Barker may publish in the future.

Co-authorship network of co-authors of Juliet N. Barker

This figure shows the co-authorship network connecting the top 25 collaborators of Juliet N. Barker. A scholar is included among the top collaborators of Juliet N. Barker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juliet N. Barker. Juliet N. Barker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Byung Jin, Wei Tan, Teresa Tsakok, et al.. (2023). Systematic review of deep learning image analyses for the diagnosis and monitoring of skin disease. npj Digital Medicine. 6(1). 180–180. 42 indexed citations
2.
Mitchell, Brittany L., Jake Saklatvala, Nick Dand, et al.. (2022). Genome-wide association meta-analysis identifies 29 new acne susceptibility loci. Nature Communications. 13(1). 702–702. 27 indexed citations
3.
Cro, Suzie, Victoria Cornelius, Francesca Capon, et al.. (2022). The interleukin 1 receptor antagonist anakinra to reduce disease severity of palmoplantar pustulosis in adults: APRICOT RCT and PLUM mechanistic study. SHILAP Revista de lepidopterología. 9(2). 1–106. 1 indexed citations
4.
Sottile, Rosa, M. Kazim Panjwani, Colleen M. Lau, et al.. (2021). Human cytomegalovirus expands a CD8 + T cell population with loss of BCL11B expression and gain of NK cell identity. Science Immunology. 6(63). eabe6968–eabe6968. 36 indexed citations
5.
Dehn, Jason, Stephen R. Spellman, Carolyn Katovich Hurley, et al.. (2019). Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR. Blood. 134(12). 924–934. 173 indexed citations
6.
7.
Lee, Yeon Joo, Robert R. Jenq, Eric R. Littmann, et al.. (2017). Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. The Journal of Infectious Diseases. 215(7). 1117–1123. 65 indexed citations
8.
Harris, Bianca, Sejal Morjaria, Eric R. Littmann, et al.. (2016). Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation. American Journal of Respiratory and Critical Care Medicine. 194(4). 450–463. 78 indexed citations
9.
Barker, Juliet N., Ekaterina Doubrovina, Craig S. Sauter, et al.. (2010). Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes. Blood. 116(23). 5045–5049. 163 indexed citations
10.
Flohr, Carsten, Suzana Radulović, W.H. Irwin McLean, et al.. (2010). Filaggrin loss-of-function mutations are associated with early onset eczema, eczema severity, and transepidermal water loss at three months of age. Journal of Investigative Dermatology. 130. 1 indexed citations
11.
Barker, Juliet N., Andromachi Scaradavou, & Cladd E. Stevens. (2009). Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood. 115(9). 1843–1849. 208 indexed citations
12.
Jackson, Karina, Richard Groves, Catherine Smith, & Juliet N. Barker. (2009). Inpatient care for psoriasis: a retrospective study of inpatient admission data and the impact of new management modalities in psoriasis. British Journal of Dermatology. 161. 28–29. 1 indexed citations
13.
Warren, Richard B., Emanuela Campalani, Stephen Eyre, et al.. (2008). Genetic Variation in Efflux Transporters Influences Outcome to Methotrexate Therapy in Patients with Psoriasis. Journal of Investigative Dermatology. 128(8). 1925–1929. 100 indexed citations
14.
Warren, Richard B., Rhodri Smith, Emanuela Campalani, et al.. (2007). Genetic variation across the methotrexate metabolic pathway and its influence upon treatment outcomes in patients with psoriasis.. British Journal of Dermatology. 157. 2–3. 4 indexed citations
15.
Brunstein, Claudio G., Juliet N. Barker, Daniel J. Weisdorf, et al.. (2007). Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood. 110(8). 3064–3070. 376 indexed citations
16.
Smith, Catherine, Karina Jackson, Amparo Sancho Pérez, et al.. (2006). Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study. British Journal of Dermatology. 155(1). 160–169. 44 indexed citations
17.
Boehncke, Wolf‐­Henning, Juliet N. Barker, Sergio Chimenti, et al.. (2006). Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus. Journal of the European Academy of Dermatology and Venereology. 20(8). 988–998. 31 indexed citations
18.
Allen, Michael H., Ana R. Sousa, C. C. Harland, et al.. (2001). Immunohistochemical evaluation of psoriatic plaques following selective photothermolysis of the superficial capillaries. British Journal of Dermatology. 145(1). 45–53. 48 indexed citations
19.
Gollnick, Harald, A. F. Finzi, Robin Marks, et al.. (1999). Optimising the Use of Tazarotene in Clinical Practice: Consensus Statement from the European Advisory Panel for Tazarotene (Zorac™). Dermatology. 199(1). 40–46. 16 indexed citations
20.
Fuller, L. Claire, Michael H. Allen, Maria Antonietta Montesu, Juliet N. Barker, & D.M. MACDONALD. (1996). Expression of E-cadherin in human epidermal non-melanoma cutaneous tumours. British Journal of Dermatology. 134(1). 28–32. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Valent Breakdown of academic impact, for papers by Alice B. Gottlieb Breakdown of academic impact, for papers by John J. O’Shea Breakdown of academic impact, for papers by Mark Lebwohl Breakdown of academic impact, for papers by J. Daniel Breakdown of academic impact, for papers by James G. Krueger Breakdown of academic impact, for papers by Alan Menter Breakdown of academic impact, for papers by Enrico Maggi Breakdown of academic impact, for papers by Olivier Hermine Breakdown of academic impact, for papers by Georg Schett
Rankless by CCL
2026